Form 4: WBA Director Acquires Phantom Stock Units
Director Compensation Disclosure
Walgreens Boots Alliance director Inderpal S. Bhandari acquired 16,820.86 phantom stock units as part of annual compensation.
Summary
- Inderpal S. Bhandari, a Director of Walgreens Boots Alliance, Inc. (WBA), acquired 16,820.86 phantom stock units.
- The transaction occurred on August 13, 2025.
- These units were granted as annual non-employee director compensation for services rendered over the prior year, under the company's 2021 Omnibus Incentive Plan.
- Each phantom stock unit is the economic equivalent of one share of WBA common stock.
- The units are valued at $11.89 per unit.
- Following this acquisition, Bhandari beneficially owns a total of 49,779.04 phantom stock units, which includes units issued in lieu of dividends.
- The units will be settled upon termination of service as a director.
Sentiment
Score: 6
Explanation: The filing details a standard, routine grant of phantom stock units to a non-employee director as part of their compensation, which is a neutral event but positively aligns director incentives with shareholder value.
Positives
- The grant of phantom stock units aligns the director's interests with shareholders, as the units are equivalent to common stock and will be settled upon termination of service.
- The compensation structure for non-employee directors is transparently disclosed.
Future Outlook
The phantom stock units are to be settled following the termination of service as a director, indicating a long-term retention mechanism.
Industry Context
The grant of phantom stock units as compensation for non-employee directors is a common practice in publicly traded companies, aligning director incentives with long-term shareholder value. This practice is consistent with standard corporate governance frameworks in the retail pharmacy and healthcare industry.
Comparison to Industry Standards
- The use of phantom stock units, which are settled upon termination of service, is a standard compensation mechanism for non-employee directors across various industries, including retail and healthcare.
- Companies like CVS Health (CVS) and Rite Aid (RAD) also utilize equity-based compensation to align director interests with company performance, though specific structures may vary.
- The practice of granting units in arrears for prior year services is also a recognized method for compensating board members.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Reference | The grant is made under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan, indicating an existing and approved corporate governance framework for director compensation. | Reinforces established compensation practices and aligns director incentives with company performance. |
Related Party Transactions
- The acquisition of phantom stock units by a director constitutes a related party transaction, as it involves compensation from the company to a member of its board. This is a standard and disclosed form of related party compensation.
Stakeholder Impact
- Shareholders: The grant aligns the director's long-term interests with shareholder value, as the phantom units are tied to the company's common stock performance.
- Employees: No direct impact on employees is indicated.
- Customers: No direct impact on customers is indicated.
Next Steps
- The phantom stock units will be settled following the termination of service as a director.
Key Dates
| Date | Description |
|---|---|
| 08/13/2025 | Date of transaction for acquisition of phantom stock units. |
| 08/15/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Keywords
Walgreens Boots Alliance, WBA, SEC Form 4, Insider Transaction, Phantom Stock Units, Director Compensation, Equity Compensation, Inderpal S. Bhandari, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.